NHS England has today announced funding of £1.93 million for a new Community Diagnostic Centre (CDC) at the Gorton Community Hub, which will be run by Manchester University NHS Foundation Trust (MFT).
The project expands MFT’s growing network of CDCs, which have provided more than 500,000 additional clinical tests and procedures over the last five years.
Funding for Phase 1 of the Gorton CDC was approved today, enabling the creation of dedicated Ultrasound and Ophthalmology diagnostic suites. These services are expected to deliver around 21,000 tests and examinations each year for patients with suspected conditions including glaucoma and diabetes. Planning work is also underway to finalise proposals for Phase 2, which will introduce a wider range of diagnostic services for additional conditions.
Gareth Adams, Chief Executive of the Clinical and Scientific Services Clinical Group, said:
“Today’s announcement is a real boost for patients in the Gorton area. Bringing essential diagnostic tests into a community setting will make it easier and more convenient for people to access appointments, helping them get the care they need sooner.
“Our teams will now begin work to establish the new diagnostic suites as quickly as possible, and we look forward to the Gorton CDC becoming an important part of our wider CDC network and diagnostic services.”
The Gorton CDC will further strengthen MFT’s expanding network of CDCs. The North Manchester CDC opened in August 2025. Diagnostic activity is currently being delivered from MFT’s existing Withington and Trafford hospital sites while construction continues on the new, purpose-built Manchester and Trafford CDC, based at Withington Community Hospital and due to open in the summer.
Mark Cubbon, Trust Chief Executive, said:
“Today’s announcement is an important step in expanding diagnostic services for the diverse communities we serve. The new Gorton CDC will play a key part in our strategy to support delivery of the NHS 10 Year Plan, with its ambition to provide more care in community settings and to give patients faster access to the tests they need, closer to home. I would like to thank all the teams involved for their hard work and commitment in bringing these developments forward.”
